Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 2.06% | 21.33 | 14.1% | $125.51m | |
| MDCO | Medicines Company | 1.72% | 53.09 | 20.3% | $104.73m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | 3.55% | 120.33 | 6.2% | $95.99m | |
| AMRN | Amarin Corporation Plc Sponsored ADR | 2.65% | 15.86 | 1.8% | $84.76m | |
| JAZZ | Jazz Pharmaceuticals Plc | 0.34% | 118.05 | 2.3% | $59.26m | |
| SAGE | SAGE Therapeutics, Inc. | 3.54% | 144.26 | 8.6% | $55.96m | |
| PRGO | Perrigo Co. Plc | 1.45% | 53.82 | 6.8% | $52.09m | |
| PCRX | Pacira Pharmaceuticals, Inc. | 4.07% | 38.10 | 10.5% | $45.60m | |
| UTHR | United Therapeutics Corporation | 0.89% | 81.97 | 14.3% | $39.43m | |
| CTLT | Catalent Inc | 1.84% | 49.23 | 2.4% | $35.25m | |
| HZNP | Horizon Pharma plc | 3.35% | 28.20 | 6.6% | $35.07m | |
| ICLR | ICON Plc | 0.27% | 141.02 | 4.1% | $32.80m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 5.62% | 64.25 | 16.9% | $32.03m | |
| AERI | Aerie Pharmaceuticals, Inc. | 2.92% | 20.28 | 6.8% | $28.14m | |
| AXSM | Axsome Therapeutics, Inc. | 13.10% | 20.63 | 2.0% | $25.52m |
Company Profile
SAGE Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.